CD56

CD56

CD56 詳細

Molecule Name
Neural cell adhesion molecule 1
分子の別称
CD56
Drug Development Progress
治験薬の数6
市販薬剤の数0
研究&開発段階Phase 2 Clinical
ターゲットの別称
Neural cell adhesion molecule 1,CD56,NCAM1,NCAM,Neural Cell Adhesion Molecule, NCAM,CD56 Antigen,N-CAM-1,MSK39,NCAM-1,Antigen Recognized By Monoclonal Antibody 5.1H11
バックグランド
CD56 is a single transmembrane glycoprotein also known as NCAM (neural cell adhesion molecule), Leu-19, or NKH1. It is a member of the Ig superfamily. The 140 kD isoform is expressed on NK and NKT cells. CD56 is also expressed in the brain (cerebellum and cortex) and at neuromuscular junctions. Certain large granular lymphocyte (LGL) leukemias, small-cell lung carcinomas, neuronal derived tumors, myelomas, and myeloid leukemias also express CD56. CD56 plays a role in homophilic and heterophilic adhesion via binding to itself or heparan sulfate.

CD56 製品リスト

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

治験薬に関する情報

英語名研究コード研究開発ステージ会社適応症臨床試験
Lorvotuzumab mertansineBB-10901; IMGN-901; huN-901-DM1; IMGN-901-TAP; huN-901-SPP-DM1Phase 2 ClinicalImmunogen Inc
Carcinoma, Merkel Cell; Leukemia; Multiple Myeloma; Neuroblastoma; Neurofibrosarcoma; Ovarian Neoplasms; Pulmonary Blastoma; Rhabdomyosarcoma; Sarcoma, Synovial; Small Cell Lung Carcinoma; Wilms Tumor
詳細
EB-DART-NK01EB-DART-NK01Phase 2 ClinicalBeijing Biotech
Small Cell Lung Carcinoma
詳細
CUBT-906CUBT-906Phase 2 ClinicalCurative Biotechnology Inc
Glioblastoma
詳細
GD2/CD56 Bi-specific CAR-T Cell Therapy (Shenzhen Geno-Immune Medical Institute)bi-4SCAR GD2/CD56Phase 2 ClinicalShenzhen Geno-Immune Medical Institute
Neoplasms
詳細
IN-B015IN-B-015; IN-B00004Phase 1 ClinicalHK inno.N Corporation
Neoplasms
詳細
DXC-006DXC-006; DAC-006Phase 1 ClinicalHangzhou Dac Biotech Company Ltd
Hematologic Neoplasms; Lung Neoplasms; Solid tumours
詳細